On April 27^th, Johanna Pfeil presented the poster “Prevalence of ROP severities in a multinational cohort of infants treated for ROP – data from the European ROP Registry (EU-ROP)” at the ARVO conference in New Orleans. Many potential new centers have approached her and the interest in the project was incredible. 

Johanna’s ARVO presentation was the first analysis from the EU-ROP registry ever presented and included 203 infants (393 eyes) from 8 different European countries. The data showed that most of the infants treated in these 8 countries have zone II, stage 3 ROP with plus disease (170 eyes) at the time of initial treatment. Also interesting is the percentage of A-ROP in our patient population: With a total of 42 eyes (10,7%) A-ROP was the third most frequent ROP severity in the EU-ROP registry. Below is Johanna’s ARVO poster for your reference.

Already some time ago, on May 10^th, Dr. Özlem Yucel from the Ondokuz Mayis University in Turkey entered the 300^th patient into the EU-ROP database! Through the amazing effort from all participating centers, we went from 200 patients to 300 patients in just a few months. We hope to continue this velocity in patient recruitment and data entry!

As of today 39 centers from 10 countries all over Europe have entered 319 patients into the EU-ROP database. 21 more centers have obtained their positive ethics vote and can now start to contribute data to the project. In addition, 21 centers from 16 countries (from which 9 countries are not represented in the registry yet) are interested in taking part in the EU-ROP project and are in close contact with us to develop their path for participation. We are very happy to see the EU-ROP project continuing to grow and evolve.